PTSHX
Price
$9.71
Change
+$0.01 (+0.10%)
Updated
Jun 12 closing price
Net Assets
10.56B
PTSRX
Price
$9.71
Change
+$0.01 (+0.10%)
Updated
Jun 12 closing price
Net Assets
10.56B
Interact to see
Advertisement

PTSHX vs PTSRX

Header iconPTSHX vs PTSRX Comparison
Open Charts PTSHX vs PTSRXBanner chart's image
PTSHX vs PTSRX Comparison Chart in %
View a ticker or compare two or three
VS
PTSHX vs. PTSRX commentary
Jun 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PTSHX is a Hold and PTSRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PTSHX (10.6B) and PTSRX (10.6B) have equal amount of cash in the bank . PTSHX pays higher dividends than PTSRX: PTSHX (4.43) vs PTSRX (3.93). PTSHX was incepted earlier than PTSRX: PTSHX (39 years) vs PTSRX (23 years). PTSRX (0.99) is less costly to investors than PTSHX (0.49). PTSHX (108.00) and PTSRX (108.00) have comparable annual turnover. PTSRX has a lower initial minimum investment than PTSHX: PTSRX (0) vs PTSHX (1000000). PTSHX annual gain was more profitable for investors over the last year : 4.98 vs. PTSRX (4.46). PTSHX return over 5 years is better than : 20.42 vs. PTSRX (17.43).
PTSHXPTSRXPTSHX / PTSRX
Total Expense Ratio0.490.9949%
Annual Report Gross Expense Ratio0.490.9949%
Fund Existence39 years23 years-
Gain YTD2.0281.818112%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets10.6B10.6B100%
Annual Yield % from dividends4.433.93113%
Returns for 1 year4.984.46112%
Returns for 3 years18.1816.42111%
Returns for 5 years20.4217.43117%
Returns for 10 years35.0328.43123%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NCIGX37.090.37
+1.01%
Nuveen International Value C
MDDRX8.930.08
+0.90%
MassMutual Diversified Value R4
ECSMX9.890.07
+0.71%
Eaton Vance Small-Cap C
SVFKX97.090.38
+0.39%
Smead Value R2
PACLX36.350.01
+0.03%
T. Rowe Price Capital Appreciation Adv